Rayvio_News_Filter
Nov 4, 1:04 PM
$NCEL ·
$MARK 🤝
NewcelX Ltd. entered a binding term sheet to divest its worldwide Mazindol/CVR portfolio to REA Holdings Inc. for
$500,000 upfront, including
$30,000 cash and shares representing a 9.4% stake in REA, plus up to
$55 million in milestones and royalties up to 8%, to support its cell-therapy focus.
0 replies